O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity

Alexis K Nagel1, Lauren E Ball

  • 1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 173 Ashley Avenue, BSB 358 MSC 509, Charleston, SC, 29425, USA.

Amino Acids
|September 1, 2014
PubMed

Insights

O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) regulate protein O-GlcNAcylation, a key nutrient-responsive modification. This review explores how OGT and OGA enzyme structure, localization, and interactions dictate substrate specificity for therapeutic potential.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cellular Signaling
  • Post-Translational Modifications

Background:

  • O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) control intracellular O-GlcNAc modification on thousands of proteins.
  • This dynamic modification responds to nutrient availability and cellular stress, impacting signaling pathways and transcriptional programs.
  • Dysregulation of OGT and OGA is linked to metabolic and age-related diseases, highlighting their importance in development and health.

Purpose of the Study:

  • To review the upstream mechanisms governing OGT and OGA substrate targeting specificity.
  • To explore how enzyme structure, splice variants, post-translational modifications, localization, and protein interactions influence OGT and OGA activity.
  • To identify potential therapeutic strategies by understanding OGT and OGA regulatory mechanisms.

Main Methods:

  • Literature review focusing on enzyme structure, post-translational modifications, localization, and protein interactions.
  • Analysis of existing research on OGT and OGA substrate specificity.
  • Synthesis of findings to elucidate regulatory mechanisms.

Main Results:

  • OGT and OGA exhibit specificity toward distinct subsets of the cellular proteome.
  • Enzyme structure, splice variants, PTMs, localization, and protein interactions are key determinants of substrate targeting.
  • Understanding these regulatory elements is crucial for deciphering the functional impacts of O-GlcNAcylation.

Conclusions:

  • The specificity of OGT and OGA is driven by complex regulatory mechanisms involving their structure and interactions.
  • Further research into these mechanisms is essential for therapeutic interventions targeting O-GlcNAc modification.
  • Harnessing the therapeutic potential of manipulating OGT and OGA activities requires a deep understanding of their upstream regulation.

Related Concept Videos

Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
2.6K
SN2 Reaction: Stereochemistry02:23

SN2 Reaction: Stereochemistry

In an SN2 reaction, the nucleophilic attack on the substrate and departure of the leaving group occurs simultaneously through a transition state. As the nucleophile approaches the substrate from the back-side, the configuration of the substrate carbon changes from tetrahedral to trigonal bipyramidal and then back to tetrahedral, leading to an inversion in the configuration of the product.
If the substrate is an achiral molecule at the α-carbon, the inversion of configuration is not...
9.7K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
93